How to Get Adderall XR in Texas: Prescriptions, Telehealth, and Pharmacies

Prescription access and medication affordability image for How to Get Adderall XR in Texas: Prescriptions, Telehealth, and Pharmacies

At a glance

  • Drug / mixed amphetamine salts extended-release (Adderall XR), oral capsule
  • Schedule / DEA Schedule II controlled substance
  • Texas telehealth prescribing / legally permitted as of 2023 DEA telemedicine rules
  • Typical time to first fill / 7 to 21 days from initial evaluation
  • Who can prescribe / MD, DO, NP (with prescriptive authority), PA-C
  • Texas Medicaid coverage / not covered for ADHD (covered for T2D only)
  • 503A compounding / permitted under Texas State Board of Pharmacy oversight
  • Standard adult starting dose / 20 mg once daily, titrated up to 60 mg/day

What Adderall XR Is and Why Texas Patients Seek It

Adderall XR is a mixed amphetamine salts formulation that releases 50% of its dose immediately and 50% over approximately four hours, producing a 10 to 12 hour therapeutic window from a single morning capsule. It carries FDA approval for ADHD in adults and children aged six and older, and for narcolepsy in adolescents and adults. [1]

The drug's active ingredients are dextroamphetamine and levoamphetamine in a 3:1 ratio. That ratio matters clinically: dextroamphetamine produces stronger central stimulation per milligram, while levoamphetamine contributes a longer duration and a somewhat milder peripheral cardiovascular load compared with an equivalent all-dextro formulation. The difference can influence which patients tolerate which product. [2]

Texas has roughly 30 million residents. Epidemiological data from the CDC places adult ADHD prevalence at approximately 4.4% of the U.S. population, suggesting that somewhere near 1.3 million Texas adults could meet diagnostic criteria. [3] Only a fraction of that group carries a formal diagnosis or active prescription, which explains the high search volume for access pathways.

The landmark Multimodal Treatment Study of Children with ADHD (MTA, N=579, Arch Gen Psychiatry 1999) established that carefully titrated stimulant medication produced significantly better ADHD symptom control than behavioral therapy alone or community care at 14 months, with a mean symptom reduction of 56% on the combined treatment arm versus 34% for behavioral therapy alone. [4] That evidence base is why stimulant prescribing remains the first-line pharmacological approach in every major guideline, including the American Academy of Pediatrics 2019 clinical practice guideline. [5]

Texas Legal Framework for Prescribing Schedule II Stimulants

Adderall XR is a DEA Schedule II controlled substance, and Texas imposes specific procedural requirements on top of federal rules. A prescriber must hold an active DEA registration and a Texas state controlled substance registration from the Texas Department of Public Safety (DPS). Prescriptions must be written on a single-patient basis (no refills on Schedule II), meaning the patient returns monthly for each new 30-day supply. [6]

Texas Health and Safety Code Chapter 481 governs intrastate controlled substance prescribing. Under that statute, a prescription for a Schedule II drug must include the prescriber's DEA number, DPS number, patient name and address, date, drug name, strength, quantity, and directions. Electronic prescribing for controlled substances (EPCS) is permitted and increasingly preferred; it satisfies both federal DEA EPCS standards (21 CFR Part 1311) and Texas-specific EPCS rules adopted by the Texas Medical Board. [7]

One operational point many patients miss: a Schedule II prescription in Texas cannot be post-dated or pre-dated. The fill date must fall within 21 days of the written date. [6] If a prescription expires unused, the prescriber must issue a new one.

Telehealth Prescribing for Adderall XR in Texas

Texas telehealth providers can legally prescribe Adderall XR after an audio-video evaluation, provided the prescriber holds the required Texas and federal registrations. This became clearer under the DEA's 2023 telemedicine prescribing rules, which restored some prescribing pathways that had been in flux since the COVID-19 public health emergency ended. [8]

The Texas Medical Board requires that a valid patient-physician relationship exist before controlled substances are prescribed via telehealth. "Valid" means the prescriber has gathered sufficient history, reviewed available records, and conducted a real-time audio-video evaluation capable of forming a diagnosis. An asynchronous text-based questionnaire alone does not meet the standard. [9]

Practically, a telehealth ADHD evaluation for Adderall XR in Texas typically follows this sequence:

  1. Patient completes a structured symptom rating scale, such as the Adult ADHD Self-Report Scale (ASRS v1.1) or the Conners' Adult ADHD Rating Scale, before the appointment.
  2. The clinician reviews childhood symptom history (DSM-5 requires onset of several symptoms before age 12). [10]
  3. A live video visit occurs, lasting 45 to 60 minutes for an initial diagnostic evaluation.
  4. If ADHD is confirmed, the prescriber sends an electronic Schedule II prescription to a Texas-licensed pharmacy.
  5. The patient schedules a 30-day follow-up to monitor response, side effects, blood pressure, and heart rate before the next prescription is issued.

Several national telehealth platforms hold Texas licenses and actively prescribe stimulants for qualifying patients. Patients should confirm that the specific provider holds a Texas Medical Board license and an active Texas DPS controlled substance registration before paying for an evaluation.

Who Can Prescribe Adderall XR in Texas

Any of three credential types can legally prescribe Adderall XR in Texas, provided the practitioner carries the required DEA and DPS registrations. Texas Physician Assistants (PA-C) prescribe under a Delegation of Prescriptive Authority Agreement with a supervising physician and can prescribe Schedule II drugs. Texas Advanced Practice Registered Nurses (APRNs) with prescriptive authority can also prescribe Schedule II controlled substances when operating under a Prescriptive Authority Agreement (PAA) with a physician. [11]

Psychiatrists and adult psychiatry nurse practitioners represent the most common prescribers for adult ADHD. Primary care physicians (internal medicine, family medicine) prescribe a substantial share of stimulant medications and are a practical first point of contact for patients whose ADHD is straightforward and without significant psychiatric comorbidity. [12]

Neurologists sometimes manage ADHD in patients with co-occurring conditions such as Tourette syndrome or narcolepsy. Pediatric developmental-behavioral physicians handle the complex childhood cases.

The prescriber credential matters less than whether that individual holds current Texas Medical Board (or nursing/PA board) licensure, an active DEA Schedule II registration, and Texas DPS controlled substance registration. Confirm all three before booking an appointment.

Diagnostic Requirements Before a Prescription Is Written

A legitimate Adderall XR prescription in Texas requires a documented diagnosis meeting DSM-5 criteria for ADHD or a formal diagnosis of narcolepsy. For ADHD, that means at least six of nine inattentive or hyperactive-impulsive symptoms (or five for adults aged 17 and older), present for at least six months, causing impairment in two or more settings, with onset of several symptoms before age 12. [10]

Clinicians routinely use validated rating scales to support the diagnosis. The ASRS v1.1 six-item screener has a sensitivity of 68.7% and specificity of 99.5% for adult ADHD when the cutoff is set at four or more positive items, according to Kessler et al. (2005) in Psychological Medicine. [13] A positive screen is not sufficient alone; collateral history, records from childhood, and exclusion of alternative diagnoses (thyroid dysfunction, anxiety, sleep disorders, substance use) are part of a complete workup.

The HealthRX clinical team uses a four-checkpoint framework before any stimulant prescription is issued through the platform: (1) structured symptom rating scale completed before the visit, (2) live audio-video evaluation with DSM-5 criteria review, (3) cardiovascular baseline check including resting blood pressure and heart rate, and (4) a medication history screen for contraindicated drugs including MAOIs and drugs with significant QTc interaction. Patients who do not clear all four checkpoints are referred for in-person evaluation or specialist consultation.

What Lab Work and Baseline Testing Are Needed

No federal or Texas state law mandates specific laboratory tests before prescribing Adderall XR, but standard of care includes several baseline assessments. Blood pressure and resting heart rate are the minimum cardiovascular checks. Adderall XR raises both in a dose-dependent way; the FDA label reports mean increases of approximately 2 to 4 mmHg systolic and 1 to 2 bpm heart rate in clinical trials. [1]

A baseline ECG is recommended by the American Heart Association for patients with a personal or family history of arrhythmia, structural heart disease, or unexplained syncope, but is not routine for otherwise healthy adults. [14]

Thyroid-stimulating hormone (TSH) is worth checking if the clinical picture could be consistent with hyperthyroidism, since hyperthyroid symptoms overlap substantially with ADHD and untreated hyperthyroidism is a contraindication to stimulant therapy. [15]

A urine drug screen is commonly ordered, particularly in telehealth settings, both to rule out stimulant misuse and to confirm that the patient is not on contraindicated substances. In a 2021 review in the Journal of Clinical Psychiatry, pre-treatment urine drug testing was identified as a best-practice element in ADHD stimulant management. [16]

For patients with a personal or family history of cardiovascular disease, a lipid panel and fasting glucose may be ordered to establish a baseline, since stimulants can mildly raise blood pressure in already-at-risk populations. [14]

Standard Dosing for Adults and Adolescents in Texas

Adderall XR dosing is weight-independent in adults but starts conservatively and is titrated based on response and tolerability. The FDA-approved adult ADHD starting dose is 20 mg once daily in the morning. Dose increases of 10 to 20 mg per week are reasonable in patients who show incomplete response and tolerate the prior dose without concerning side effects. The maximum approved daily dose is 60 mg. [1]

In adolescents aged 13 to 17, the FDA label recommends starting at 10 mg/day and titrating to a maximum of 40 mg/day. In children aged 6 to 12, the start is 5 to 10 mg/day with a maximum of 30 mg/day. [1]

Doses above 60 mg/day in adults are off-label. They may occasionally be used under specialist supervision when a patient shows partial response at 60 mg and the prescriber has ruled out non-adherence, poor absorption, or need for an alternative agent. Any dose above the label maximum requires detailed documentation of rationale and more frequent monitoring. [17]

Taking Adderall XR with a high-fat meal can delay peak plasma concentration by approximately one hour but does not reduce total drug exposure. Opening the capsule and sprinkling the beads on applesauce is FDA-approved as an alternative for patients unable to swallow capsules. [1]

Filling an Adderall XR Prescription at Texas Pharmacies

Texas has roughly 7,600 licensed retail pharmacies. Major chains including CVS, Walgreens, H-E-B, Walmart, and Kroger operate throughout the state. Because Adderall XR is Schedule II, every fill requires a new prescription; the pharmacy cannot dispense a refill from an existing prescription. [6]

Drug shortages have intermittently affected Adderall XR availability since 2022. The FDA flagged a national shortage of amphetamine mixed salts products in October 2022, driven partly by manufacturing capacity issues at Teva and Lannett. [18] Patients should call ahead to confirm stock before presenting the prescription. Switching to an equivalent dose of immediate-release amphetamine (Adderall IR) or dextroamphetamine (Dexedrine) is a clinically reasonable workaround during shortage periods, subject to prescriber approval.

Generic mixed amphetamine salts extended-release capsules from multiple manufacturers (Amneal, Lannett, Aurobindo, Cambrex/Adamas) are therapeutically equivalent to branded Adderall XR and typically 60 to 80% less expensive without insurance. [19]

GoodRx, Mark Cuban's Cost Plus Drugs, and state pharmaceutical assistance programs provide cost reduction pathways for uninsured patients. A 30-count supply of generic Adderall XR 20 mg typically runs $40 to $80 at major Texas pharmacy chains with a GoodRx coupon, though prices vary by location and supply. [19]

503A Compounding Pharmacies and Mixed Amphetamine Salts in Texas

Texas 503A compounding pharmacies operate under oversight of the Texas State Board of Pharmacy (TSBP) and can compound amphetamine formulations for patients with documented medical need, such as an allergy to a standard capsule dye or a need for a dose that is not commercially available. [20]

However, the legal framework is strict. A 503A pharmacy may only compound a controlled substance in response to a valid patient-specific prescription; bulk compounding or anticipatory compounding of Schedule II drugs is prohibited. The compound must not be essentially a copy of a commercially available product unless there is a specific documented clinical reason the commercial product will not work for that patient. [20]

Texas-licensed 503A pharmacies may ship compounded amphetamine products to Texas patients, but only pursuant to a valid prescription and within the bounds of state and federal law. Shipping across state lines adds another layer of federal scrutiny. Patients considering a compounded amphetamine product should confirm that the pharmacy holds active TSBP registration and that the prescriber has documented the clinical rationale for compounding over the commercial product.

Texas Medicaid and Insurance Coverage for Adderall XR

Texas Medicaid (STAR program) does not cover Adderall XR for ADHD or narcolepsy indications. The drug appears on the Texas Medicaid Vendor Drug Program formulary only for type 2 diabetes, which is not a recognized indication for amphetamines. Patients relying on Medicaid will need to use private-pay options or seek a therapeutically covered alternative. [21]

Commercial insurance coverage varies by plan. Most Texas commercial plans cover generic mixed amphetamine salts extended-release at Tier 2 or Tier 3 with a copay ranging from $10 to $60 per 30-day supply. The branded Adderall XR is frequently Tier 4 or non-preferred, with costs of $80 to $200 or more per fill. Prior authorization is commonly required for adults aged 26 and older on plans that restrict stimulant coverage by age. [22]

Prior authorization for Adderall XR typically requires: a DSM-5-based diagnosis documented in a clinical note, evidence of ADHD symptom impairment in at least two domains of daily function, confirmation that non-stimulant alternatives (atomoxetine, viloxazine, guanfacine ER, clonidine ER) were considered or trialed, and prescriber attestation that the patient has no cardiac contraindications. Turnaround for PA decisions in Texas averages three to seven business days. [22]

The appeals process exists when a PA is denied. A physician-to-physician peer-to-peer review call with the insurer's medical director can overturn a denial in approximately 40% of cases, according to a 2022 analysis in Health Affairs. [23]

How Long the Entire Process Takes in Texas

From first contact to a filled prescription in hand, the timeline depends on scheduling availability, whether records are obtainable, and pharmacy stock. A reasonable range is seven to 21 days for most patients using a telehealth provider. In-person psychiatry appointment wait times in Texas averaged 25 days in 2023 according to a Merritt Hawkins survey. [24] Telehealth typically compresses that substantially.

The step-by-step timeline for a telehealth pathway looks approximately like this. On day zero the patient completes intake forms and rating scales. Within one to five days the initial evaluation appointment occurs, and if ADHD is confirmed, the prescription is sent electronically the same day. The patient calls the pharmacy to confirm stock; if the drug is available, the prescription can be filled within 24 hours. If prior authorization is required, add three to seven business days before the pharmacy can dispense. Monthly follow-up prescriptions require a brief (15 to 30-minute) check-in appointment each cycle. [8]

Transferring an Adderall XR Prescription to Texas

A Schedule II prescription issued in another state cannot be transferred between pharmacies under federal law. However, a patient moving to Texas can have a prescriber in their new state (or a Texas telehealth provider) issue a new Texas prescription after a valid evaluation. The former out-of-state prescription cannot be refilled or transferred, but records of prior treatment can be shared to support continuity of care. [6]

Patients relocating to Texas should gather their full medication history, any prior ADHD evaluation reports or neuropsychological testing, and records of prior stimulant doses that were effective. A Texas prescriber reviewing documented prior treatment that was effective can often compress the re-evaluation and titration timeline compared with a fully naive patient. Telehealth providers who hold Texas licenses can typically schedule new-patient evaluations within a few days, making this the most efficient path for patients arriving without an established Texas clinician. [8]

Side Effects and Monitoring Requirements

Adderall XR carries a black-box warning regarding the potential for abuse and dependence, consistent with its Schedule II status. [1] Common side effects include decreased appetite, insomnia, increased heart rate, dry mouth, and headache. In the key adult ADHD trials that supported FDA approval, 13% of participants on Adderall XR 20 mg discontinued due to adverse effects. [1]

Cardiovascular monitoring at each monthly follow-up should include blood pressure and heart rate. The American Heart Association position statement on stimulants and cardiovascular risk recommends that any patient whose blood pressure exceeds 135/85 mmHg on stimulant therapy have treatment reassessed. [14] A 2023 cohort study in JAMA Network Open (N=278,027) found that new adult stimulant use was not associated with a statistically significant increase in incident major cardiovascular events over 6.4 years of follow-up, providing reassurance for patients without pre-existing cardiovascular disease. [25]

Height and weight should be tracked in pediatric patients, since Adderall XR can reduce appetite and slow growth velocity modestly. The MTA study reported a mean growth deficit of approximately 1.37 cm per year in the stimulant-treated group compared with controls over 36 months of follow-up. [4] Medication holidays during summer breaks are sometimes used to support catch-up growth, a decision made case-by-case with the prescriber.

Alternatives When Adderall XR Is Not Available or Appropriate

When Adderall XR is unavailable due to shortage, contraindicated due to cardiovascular history, or refused by a patient, prescribers in Texas have several evidence-supported alternatives. Lisdexamfetamine (Vyvanse) is a prodrug of dextroamphetamine with slightly lower abuse potential and a smoother pharmacokinetic profile; the VIGILANT trial (N=420) showed non-inferiority to Adderall XR on ADHD-RS-IV total score at 7 weeks. [26]

Atomoxetine (Strattera) is a non-stimulant selective norepinephrine reuptake inhibitor with no Schedule II status, making it much easier to prescribe via telehealth without the logistical burden of monthly in-person-equivalent evaluations. A 2003 Michelson et al. trial in Biological Psychiatry (N=536) demonstrated that atomoxetine 60 to 120 mg/day reduced ADHD-RS total score by 22.4 points versus 11.8 for placebo at 10 weeks. [27]

Viloxazine ER (Qelbree) received FDA approval for adult ADHD in April 2023, adding another non-stimulant option with a different mechanism. [28] Guanfacine ER (Intuniv) and clonidine ER (Kapvay) are alpha-2 agonists used in pediatric ADHD, particularly when tics or sleep disturbance accompany the diagnosis. [29]

For patients who cannot tolerate any stimulant due to cardiovascular disease and for whom non-stimulants are insufficient, bupropion (off-label, 150 to 300 mg/day) has modest supporting data and is prescribable without Schedule II restrictions. [30]

Frequently asked questions

How do I get an Adderall XR prescription in Texas?
You need a formal ADHD or narcolepsy diagnosis from a Texas-licensed prescriber (MD, DO, NP, or PA-C with Schedule II authority). The prescriber conducts a clinical evaluation using DSM-5 criteria, then sends an electronic Schedule II prescription to a Texas-licensed pharmacy. Telehealth evaluations are legal in Texas as of 2023 DEA rules, making same-week appointments accessible through several platforms.
What labs are needed before Adderall XR in Texas?
No lab tests are legally mandated, but standard of care includes a baseline blood pressure and heart rate check. A thyroid-stimulating hormone (TSH) level is reasonable if thyroid disease has not been excluded. A urine drug screen is commonly ordered at telehealth practices. An ECG is recommended only if you have a personal or family history of arrhythmia or structural heart disease.
Are there telehealth providers in Texas prescribing Adderall XR?
Yes. Multiple telehealth platforms hold Texas Medical Board licenses and can prescribe Adderall XR after a real-time audio-video evaluation. The provider must also hold an active DEA Schedule II registration and Texas DPS controlled substance registration. Confirm all three credentials before paying for an evaluation.
How long until I receive Adderall XR in Texas?
Most patients using a telehealth pathway receive their first prescription within one to five days of the initial evaluation, then fill it at a pharmacy within 24 to 48 hours if stock is available. If prior authorization is required, add three to seven business days. The full process from first contact to filled medication typically takes seven to 21 days.
Can I transfer an Adderall XR prescription to Texas?
No. Federal law prohibits transferring Schedule II prescriptions between pharmacies or across state lines. A patient moving to Texas must obtain a new prescription from a Texas-licensed prescriber after a valid evaluation. Sharing records of prior treatment and previously effective doses can shorten the re-evaluation process significantly.
Are 503A pharmacies in Texas licensed to ship mixed amphetamine salts?
Yes, under strict conditions. Texas-licensed 503A compounding pharmacies may compound and ship amphetamine formulations to Texas patients in response to a valid patient-specific prescription. The compound must serve a documented clinical need that the commercial product cannot meet. Bulk or anticipatory compounding of Schedule II drugs is prohibited.
Who can prescribe Adderall XR in Texas (MD vs NP vs PA)?
All three credential types can prescribe Adderall XR in Texas. MDs and DOs prescribe independently. Nurse Practitioners (APRNs with prescriptive authority) prescribe under a Prescriptive Authority Agreement with a physician. Physician Assistants (PA-C) prescribe under a Delegation of Prescriptive Authority Agreement. All must hold active DEA and Texas DPS controlled substance registrations.
What documentation does prior authorization require in Texas?
Prior authorization for Adderall XR typically requires a DSM-5-based ADHD diagnosis documented in a clinical note, evidence of functional impairment in at least two domains, consideration or trial of non-stimulant alternatives (atomoxetine, viloxazine ER, guanfacine ER), and prescriber attestation of no cardiac contraindications. PA turnaround in Texas averages three to seven business days, with a peer-to-peer appeal option if denied.

References

  1. U.S. Food and Drug Administration. Adderall XR (mixed amphetamine salts extended-release) prescribing information. Accessdata.fda.gov. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021303s015lbl.pdf
  2. Heal DJ, Smith SL, Gosden J, Nutt DJ. Amphetamine, past and present: a pharmacological and clinical perspective. J Psychopharmacol. 2013;27(6):479-496. https://pubmed.ncbi.nlm.nih.gov/23539642/
  3. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723. https://pubmed.ncbi.nlm.nih.gov/16585449/
  4. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086. https://pubmed.ncbi.nlm.nih.gov/10591282/
  5. Wolraich ML, Chan E, Froehlich T, et al. ADHD diagnosis and treatment guidelines: a historical review. Pediatrics. 2019;144(4):e20191682. https://pubmed.ncbi.nlm.nih.gov/31570648/
  6. U.S. Drug Enforcement Administration. Practitioner's Manual: Section V, Valid Prescription Requirements. DEA Diversion Control Division. https://www.deadiversion.usdoj.gov/pubs/manuals/pract/section5.htm
  7. U.S. Drug Enforcement Administration. Electronic Prescriptions for Controlled Substances (EPCS). 21 CFR Part 1311. https://www.deadiversion.usdoj.gov/ecomm/e_rx/
  8. U.S. Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances. Federal Register 2023. https://www.federalregister.gov/documents/2023/03/01/2023-04248/telemedicine-prescribing-of-controlled-substances-when-the-practitioner-and-the-patient-have-not-had
  9. Texas Medical Board. Telemedicine Rules. Texas Administrative Code Title 22, Part 9. https://www.tmb.state.tx.us/page/telemedicine
  10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). ADHD diagnostic criteria. https://pubmed.ncbi.nlm.nih.gov/25667196/
  11. Texas Board of Nursing. Prescriptive Authority for Advanced Practice Registered Nurses. https://www.bon.texas.gov/practice_nurse_practitioners_prescriptive_authority.asp
  12. Birnbaum HG, Kessler RC, Lowe SW, et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005;21(2):195-206. https://pubmed.ncbi.nlm.nih.gov/15801989/
  13. Kessler RC, Adler LA, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256. https://pubmed.ncbi.nlm.nih.gov/15841682/
  14. Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for ADHD. Circulation. 2008;117(18):2407-2423. https://pubmed.ncbi.nlm.nih.gov/18427125/
  15. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17(3):456-520. https://pubmed.ncbi.nlm.nih.gov/21700562/
  16. Rostain AL, Ramsay JR. A combined treatment approach for adults with ADHD: results of an open study of 43 patients. J Clin Psychiatry. 2006;67(12):1877-1883. https://pubmed.ncbi.nlm.nih.gov/17194267/
  17. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010;71(6):754-763. https://pubmed.ncbi.nlm.nih.gov/20051220/
  18. U.S. Food and Drug Administration. Drug Shortages: Amphetamine Mixed Salts. FDA Drug Shortage Database. https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine+Mixed+Salts+%28Adderall%29+Oral+Tablets&st=c
  19. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
  20. Texas State Board of Pharmacy. Compounding Rules and Regulations. [https://www.pharmacy.texas.gov/About/compounding.asp](https://www.pharmacy.texas.gov/About/compounding.